Home » Topics » BioWorld Science

BioWorld Science
RSS

Canadian scientists identify new target for respiratory drugs

Nov. 28, 1996

Intracardiac illuminator offered for licensing

Nov. 28, 1996

Novel vaccine delivery system available for licensing

Nov. 28, 1996

Licenses available for lung function monitor

Nov. 28, 1996

Exclusive worldwide rights offered for peptide-cleaving endopeptidase

Nov. 28, 1996

Cancer diagnostic based on p53 offered for licensing

Nov. 28, 1996

Exclusive worldwide rights offered for human full-length TRK-B

Nov. 28, 1996

Diagnostic kits for beta-thalassemia available for licensing

Nov. 28, 1996

Purified or recombinant TAP 29 with anti-HIV activity available for licensing

Nov. 28, 1996

Zeneca submits antimigraine Rx for approval

Nov. 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...